Cargando…
An Open-label, Self-control, Prospective Study on Cognitive Function, Academic Performance, and Tolerability of Osmotic-release Oral System Methylphenidate in Children with Attention-deficit Hyperactivity Disorder
BACKGROUND: Attention-deficit hyperactivity disorder (ADHD) is the most common mental and behavioral disorder in school-aged children. This study evaluated the effect of osmotic-release oral system (OROS) methylphenidate (MPH) on cognitive function and academic performance of Chinese school-aged chi...
Autores principales: | Zheng, Yi, Liang, Jian-Min, Gao, Hong-Yun, Yang, Zhi-Wei, Jia, Fu-Jun, Liang, Yue-Zhu, Fang, Fang, Li, Rong, Xie, Sheng-Nan, Zhuo, Jian-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795269/ https://www.ncbi.nlm.nih.gov/pubmed/26608976 http://dx.doi.org/10.4103/0366-6999.168948 |
Ejemplares similares
-
Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder
por: Buitelaar, Jan K, et al.
Publicado: (2009) -
Dose titration of osmotic release oral system methylphenidate in children and adolescents with attention-deficit hyperactivity disorder: a retrospective cohort study
por: Xu, Youran, et al.
Publicado: (2023) -
Osmotic release oral system-methylphenidate improves neural activity during low reward processing in children and adolescents with attention-deficit/hyperactivity disorder()
por: Mizuno, Kei, et al.
Publicado: (2013) -
Methylphenidate use in children with attention deficit hyperactivity disorder
por: Machado, Felipe Salles Neves, et al.
Publicado: (2015) -
Cost-Effectiveness of Extended-Release Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Sub-Optimally Treated with Immediate Release Methylphenidate
por: van der Schans, Jurjen, et al.
Publicado: (2015)